Asthma: symptoms, triggers and inhaler treatment
Asthma narrows the airways in episodes, so the symptoms come and go: wheeze, cough, a tight chest and breathlessness, often worse at night or with exercise. It is controlled rather than cured, and the medicine that eases your symptoms at once is not the one that keeps you well. This guide covers the symptoms and triggers, how asthma is diagnosed, what reliever and preventer treatments do, including montelukast tablets, how to tell when control is slipping and which signs mean an emergency.
What are the symptoms?
Four symptoms make up the usual picture: a wheeze, a dry cough, tightness across the chest and breathlessness. What points to asthma is not any one of them but the pattern. Symptoms vary from day to day, are often worse in the early morning or at night, and are set off by particular things.
A cough alone can be the whole presentation, particularly in children and particularly at night, and it is often mistaken for one infection after another. Breathlessness on exercise that settles with rest is another common form.
Symptoms that are constant and unchanging, or that came on suddenly in an older adult who has never had them, point away from asthma and towards other causes that need a different assessment. Breathlessness with swollen ankles, with chest pain, or that wakes you gasping is not a reason to reach for an inhaler; it is a reason to be examined.
What triggers it?
Triggers differ from person to person, and the ones worth knowing are your own. Common ones are house dust mite, animal dander, pollen, mould, cold air, exercise, cigarette smoke, strong smells and air pollution. Respiratory infections are a frequent reason for a flare, which is why a cold can turn into a fortnight of poor control.
Some medicines matter too. A minority of people with asthma react to aspirin and other non-steroidal anti-inflammatory painkillers; the summary of product characteristics (SmPC) of montelukast points out that taking it does not remove the need to avoid these painkillers in aspirin-sensitive asthma. Beta blockers are the other group: the SmPC of an authorised propranolol product states that it must not be used if there is a history of bronchial asthma or bronchospasm. Tell anyone who prescribes for you that you have asthma.
Air and housing play a part for some people: dusty air, damp and mould in a home over the winter, and heat combined with humidity, which makes exertion harder and can feel like worsening asthma. Reflux, excess weight and untreated hay fever can all make asthma harder to control and are worth treating in their own right; our guide to heartburn and acid reflux covers reflux.
How is asthma diagnosed?
The diagnosis starts with the history, because the pattern of symptoms carries most of the weight: what brings them on, when they are worst, whether they respond to a reliever, and whether there is eczema, hay fever or asthma in the family.
Breathing tests support it. The usual measurement, spirometry, looks at how fast and how much air you can blow out, before and after a reliever inhaler, to show that the narrowing is reversible. A peak flow meter used at home over a couple of weeks can show the day-to-day variation that is typical of asthma. Tests that look at airway inflammation or at allergy may be added.
Two cautions. Normal breathing tests between episodes do not exclude asthma, because the abnormality is intermittent by nature; and a good response to a reliever does not by itself confirm it. This is why a first diagnosis rests on breathing tests that a questionnaire cannot replace: before a first prescription the doctor asks for their results or recommends that you are examined by a doctor in Malta.
Reliever and preventer inhalers: what each one does
A reliever opens narrowed airways quickly and for a few hours. Salbutamol is the usual one: the SmPC of an authorised salbutamol inhaler describes a fast onset, within 5 minutes, and an effect lasting 4 to 6 hours in most people. In the Medicines Authority register, 16 authorised products contain salbutamol as the only active substance, and all of them are prescription-only medicines (POM); our page on the salbutamol inhaler Ventolin describes it in detail. A reliever treats the symptom and does nothing to the underlying inflammation.
A preventer works on the inflammation that makes the airways over-sensitive. It is usually an inhaled corticosteroid such as fluticasone, sometimes combined with a long-acting bronchodilator in one device. It does nothing for you in the moment, which is why it gets abandoned. The salbutamol SmPC states that bronchodilators should not be the only or main treatment in persistent asthma, and that people prescribed a regular inhaled corticosteroid should keep taking it even when their symptoms ease.
The consequence is counterintuitive: needing the reliever more often is not a sign that it is working well. The same SmPC warns that overuse of short-acting relievers may mask the progression of the disease and raises the risk of severe flare-ups, and the package leaflet treats use more than twice a week, not counting a dose before exercise, as a sign of poorly controlled asthma that needs a review. Which regimen suits you is a decision for a doctor; do not copy someone else's inhaler routine.
Montelukast: a preventer taken as a tablet
Not every preventer is an inhaler. Montelukast is a tablet that blocks the receptors for leukotrienes, substances released by cells such as mast cells and eosinophils, which the SmPC links with narrowing of the airways, mucus and inflammation in asthma. In the Medicines Authority register, 16 authorised products contain montelukast, among them 4 mg and 5 mg chewable tablets and 10 mg film-coated tablets, and every one of them is a prescription-only medicine (POM).
The SmPC of an authorised 10 mg tablet gives two uses in asthma (section 4.1): as an add-on in mild to moderate persistent asthma not controlled well enough by an inhaled corticosteroid with an as-needed reliever, and to prevent asthma in which narrowing of the airways on exercise is the main feature. In people who take it for asthma, it can also ease seasonal hay fever. For some children aged 2 to 5 with mild persistent asthma, no recent serious attacks and no ability to use an inhaled corticosteroid, the SmPC of a 4 mg chewable tablet allows it as an alternative to a low-dose inhaled corticosteroid.
Montelukast does not treat an attack: the SmPC says never to use it for acute asthma, to keep the usual reliever to hand and not to swap it abruptly for a corticosteroid. It is taken every day, also when asthma is under control. The table shows the doses in the SmPCs of three authorised products.
| Montelukast form | Age group in the SmPC | Usual dose in the SmPC |
|---|---|---|
| 10 mg film-coated tablet | Adults and adolescents aged 15 and over | One tablet a day in the evening, with or without food |
| 5 mg chewable tablet | Children aged 6 to 14 | One tablet a day in the evening; if taken around a meal, 1 hour before or 2 hours after food |
| 4 mg chewable tablet | Children aged 2 to 5, under adult supervision | One tablet a day in the evening; if taken around a meal, 1 hour before or 2 hours after food |
Montelukast side effects, including changes in mood and behaviour
The montelukast SmPC warns that neuropsychiatric events, such as changes in behaviour, depression and suicidal thoughts and behaviour, have been reported in all age groups (section 4.4). They may be serious and may continue if treatment is not withdrawn, which is why the SmPC says montelukast should be stopped if such symptoms appear. Watch for nightmares, difficulty sleeping, sleepwalking, anxiety, agitation or aggression and low mood, in yourself or in your child, and tell the doctor promptly.
In an emergency, call 112. Supportline 179 (Appoġġ): 24/7, free from landlines and mobiles. Richmond Foundation helpline 1770: Monday to Friday 8 am to 8 pm, Saturday until 4 pm.
Effects listed as common in the SmPC include headache, diarrhoea, nausea, vomiting, rash, fever and raised liver enzymes. Rarely, inflamed blood vessels with raised eosinophils (Churg-Strauss syndrome) have been reported; a new rash, worsening breathing, tingling or numbness needs a doctor's assessment. In pregnancy and while breastfeeding, the SmPC allows montelukast only if it is clearly essential.
Inhaler technique, spacers and the things that quietly go wrong
An inhaler used poorly gets only part of the dose into your lungs, and technique drifts even after years of use. The salbutamol SmPC asks for technique to be checked so that pressing the canister is timed with breathing in. Ask a pharmacist to watch you use your device; it takes a minute.
A spacer helps if you find it hard to press and breathe in at the same moment, and the SmPC mentions a paediatric spacer with a face mask for babies and young children. Rinsing your mouth with water after an inhaled corticosteroid can help with hoarseness and oral thrush, which the SmPC of an authorised fluticasone inhaler lists among its common and very common side effects.
Know how much is left. The salbutamol SmPC warns that an inhaler without a dose counter can keep spraying after its 200 puffs without the right dose; it suggests keeping a record of the puffs used and recommends having a spare inhaler. The leaflet says to store it below 30 °C, away from frost and sunlight, and never to expose the canister to more than 50 °C, which matters in a car parked in the summer sun.
A written action plan agreed with a doctor, which says what to do when symptoms worsen, turns a frightening episode into a sequence of steps.
Signs that control is slipping, and signs of an emergency
Control is slipping when you use the reliever more often than you used to, wake at night with symptoms, find that ordinary activity brings on a wheeze, or notice that your peak flow readings are lower or more variable. The salbutamol SmPC adds a specific sign: a dose that used to work no longer gives quick relief lasting at least three hours. That is the moment to seek medical advice promptly, not to use more reliever.
Get medical advice without waiting if your symptoms do not respond to the reliever as they normally do, if you need it again within a few hours, or if a flare has gone on for days with no improvement.
Call 112 or go to Accident and Emergency (A&E) if you are too breathless to speak in full sentences, if your lips or fingers look blue, if the reliever is not working at all, if you are exhausted by the effort of breathing, or if a child is drowsy or struggling to feed. A silent chest, where the wheeze disappears while breathlessness gets worse, is a serious sign, not an improvement. What to take while help is on its way belongs in your own action plan agreed with a doctor. Do not drive yourself to hospital during a severe attack.
Living with asthma
Most people with asthma live without restriction, and the aim of treatment is exactly that: no symptoms limiting what you do, no night waking, and a reliever that sits unused for long stretches.
The habits that get people there are unglamorous. Take the preventer every day, including when you feel well, because that is when it is working. Have your technique checked. Keep a spare reliever and keep track of the puffs. Treat hay fever properly if you have it. Stop smoking and avoid smoky environments, including vaping around you. Keep to a healthy weight, because excess weight changes how much breathlessness a given degree of narrowing produces.
Exercise is to be encouraged rather than avoided; if exertion reliably brings on symptoms, that is a treatable problem, not a reason to stop.
Finally, keep your own record: the inhalers and tablets you use, the doses, your usual peak flow and the dates of flares. It makes any future assessment quicker and better informed.
Continuing an asthma medicine after a written review
If your asthma has been diagnosed and your treatment is stable, a request to continue a medicine you already use goes through the Online Prescription questionnaire. You fill in a medical questionnaire about the medicine, your health and other medicines you take, and the doctor reviews your answers in writing. If the doctor has questions, they ask them in writing in the chat in your account, and you get an email to let you know. There is no video call, no phone call and no live chat.
With a first diagnosis, poor control or a recent flare, the doctor may ask for breathing test results, may recommend that you see a doctor in Malta, or may decline. For some conditions, and in some individual cases, it is advisable to see a doctor in person; the doctor may recommend this. A severe attack is never handled through a questionnaire: call 112. Our page on how the written review works describes the steps.
If the doctor issues a prescription, you receive it as a PDF by email. You print it and bring it on paper to a pharmacy in Malta together with photo identification. Your prescription is issued in the standard EU cross-border format set out in Directive 2012/52/EU. A pharmacy in Malta may dispense it; the decision rests with the pharmacist. Take the prescription to a pharmacy within six months of the date on it; a prescription for an antibiotic cannot be dispensed more than ten days after its date of issue.
What does it cost?
Two separate costs are involved. The button on this page shows the fee for the doctor's review, and the medicine itself is paid for at the pharmacy. It is not an ePrescription and does not appear in myHealth; it is outside POYC and the Government Formulary List, and you pay for the medicine at the pharmacy in full.
Who reviewed this guide
Medically reviewed by Damian Wojno, a doctor registered with the Polish Medical Chamber, licence no. 3211301. The doctor is not registered with the Medical Council of Malta. The guide is general information and does not replace the action plan you have agreed with your own doctor.
Can asthma be diagnosed online?
Not from a questionnaire alone. A first diagnosis rests on the history and on breathing tests, because the pattern has to be told apart from other causes of cough and breathlessness. Before any first prescription, the doctor asks for the results of those tests or recommends that you are examined by a doctor in Malta.
Why do I need a preventer if the reliever works?
Because they do different jobs. The reliever opens the airways for a few hours and leaves the underlying inflammation untouched; the preventer treats that inflammation and is what reduces the risk of a severe attack. Feeling nothing from the preventer is normal and is not a reason to stop it. Needing the reliever more often is a signal to have the treatment reviewed.
How often is it acceptable to use a reliever inhaler?
The package leaflet of an authorised salbutamol inhaler treats use more than twice a week to relieve symptoms, not counting a dose before exercise, as a sign of poorly controlled asthma that needs a review, and its SmPC says that as-needed use should not exceed four times a day. Rising use, waking at night or symptoms during ordinary activity are reasons to have the treatment reviewed rather than to take more reliever.
What is montelukast used for in asthma?
Montelukast is a tablet taken once a day in the evening, as an add-on preventer when an inhaled corticosteroid with an as-needed reliever does not control asthma well enough, or to prevent asthma that is set off mainly by exercise. It does not treat an attack, and all 16 authorised montelukast products in the Medicines Authority register are prescription-only medicines (POM).
What are the signs of an asthma attack that needs emergency help?
Being too breathless to speak in full sentences, blue lips or fingers, a reliever that is not working, exhaustion from the effort of breathing, or a child who is drowsy or cannot feed. A chest that has gone quiet while breathlessness is worse is a serious sign. Call 112 or go to Accident and Emergency (A&E), and do not drive yourself.
Can hot, dusty or damp weather make asthma worse?
For some people, noticeably. Dusty air, damp and mould at home over the winter, and heat with high humidity can all bring on symptoms or make exertion harder. Knowing your own triggers lets you take the preventer seriously before a difficult season, and the inhaler itself should be kept away from heat.
My inhaler has run out. Can it be continued from a written review?
Where the diagnosis is established, the treatment is unchanged and your asthma is stable, the doctor can assess a request to continue it from your answers and from any records the doctor asks you to send through the chat in your account. Where control is poor, the dose or device needs changing, you have had a recent flare or the diagnosis itself is uncertain, the doctor may recommend that you are seen in person. If you are struggling to breathe now, call 112.
- Medicines Authority: Monkasta 10 mg film-coated tablets (MA982/01002), with summary of product characteristics
- Medicines Authority: Actamone 4 mg chewable tablets (MA1341/00101)
- Medicines Authority: Actamone 5 mg chewable tablets (MA1341/00102)
- Medicines Authority: Ventolin Evohaler 100 micrograms pressurised inhalation suspension (MA192/03302), with summary of product characteristics and package leaflet
- Medicines Authority: Flixotide Diskus 100 micrograms inhalation powder (MA192/00404)
- Medicines Authority: Propranolol hydrochloride 10 mg/5 ml oral solution (MA1296/01902)
- Prescription and Dispensing Requirements Rules (S.L. 458.49), rule 4 (legislation.mt)
- Commission Implementing Directive 2012/52/EU on the recognition of medical prescriptions issued in another Member State (EUR-Lex)